Skip to Main Content (Press Enter)
×
Home
People
Projects
Fields
Units
Outputs
Third Mission
IT
EN
☰
Expertise & Skills
|
Expertise & Skills
unimi.it
IT
EN
×
Home
People
Projects
Fields
Units
Outputs
Third Mission
☰
Projects
Development of Sars-CoV-2 MPro protease inhibitors as 'direct-acting antivirals' for the pharmacological treatment of coronavirus infections
Project
Overview
Research Areas
Overview
Departments involved
Dipartimento di Scienze Biomediche e Cliniche
Principale
Type
ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali
Funder
INTESA SANPAOLO S.P.A.
External Organization
Funding Organization
Date/time interval
April 1, 2023 - March 31, 2024
Project duration
12 months
Research Areas
Concepts
Old Academic field (valid till 24/06/2024)
Settore MED/42 - Igiene Generale e Applicata
